Operating Income Summary of AstraZeneca PLC

AstraZeneca PLC's latest annual operating income in 2023 was 8.19 Billion USD , up 118.07% from previous year.
AstraZeneca PLC's latest quarterly operating income in 2024 Q2 was 2.84 Billion USD , down -11.85% from previous quarter.
AstraZeneca PLC reported an annual operating income of 3.75 Billion USD in 2022, up 255.78% from previous year.
AstraZeneca PLC reported an annual operating income of 1.05 Billion USD in 2021, down -79.54% from previous year.
AstraZeneca PLC reported a quarterly operating income of 3.24 Billion USD for 2024 Q1, up 152.43% from previous quarter.
AstraZeneca PLC reported a quarterly operating income of 1.95 Billion USD for 2023 Q3, down -20.44% from previous quarter.

Annual Operating Income Chart of AstraZeneca PLC (2023 - 1990)

Historical Annual Operating Income of AstraZeneca PLC (2023 - 1990)

Year	Operating Income	Operating Income Growth
2023	8.19 Billion USD	118.07%
2022	3.75 Billion USD	255.78%
2021	1.05 Billion USD	-79.54%
2020	5.16 Billion USD	76.54%
2019	2.92 Billion USD	-13.67%
2018	3.38 Billion USD	-7.89%
2017	3.67 Billion USD	-24.99%
2016	4.9 Billion USD	19.15%
2015	4.11 Billion USD	92.51%
2014	2.13 Billion USD	-42.43%
2013	3.71 Billion USD	-54.44%
2012	8.14 Billion USD	-36.32%
2011	12.79 Billion USD	11.32%
2010	11.49 Billion USD	-0.42%
2009	11.54 Billion USD	26.24%
2008	9.14 Billion USD	12.97%
2007	8.09 Billion USD	-1.48%
2006	8.21 Billion USD	26.36%
2005	6.5 Billion USD	43.0%
2004	4.54 Billion USD	10.61%
2003	4.11 Billion USD	-5.67%
2002	4.35 Billion USD	-22.94%
2001	5.65 Billion USD	54.3%
2000	3.66 Billion USD	37.09%
1999	2.67 Billion USD	46.83%
1998	1.82 Billion USD	1.71%
1997	1.79 Billion USD	0.23%
1996	1.78 Billion USD	39.44%
1995	1.28 Billion USD	24.33%
1994	1.03 Billion USD	-1.06%
1993	1.04 Billion USD	142.61%
1992	429.22 Million USD	-66.37%
1991	1.27 Billion USD	10.26%
1990	1.15 Billion USD	0.0%

Year	Operating Income	Operating Income Growth
2024 Q2	2.84 Billion USD	-11.85%
2024 Q1	3.24 Billion USD	152.43%
2023 Q3	1.95 Billion USD	-20.44%
2023 Q4	1.23 Billion USD	-36.85%
2023 FY	8.19 Billion USD	118.07%
2023 Q1	2.54 Billion USD	845.32%
2023 Q2	2.45 Billion USD	-3.65%
2022 Q4	-342 Million USD	-127.47%
2022 Q2	539 Million USD	-38.61%
2022 FY	3.75 Billion USD	255.78%
2022 Q3	1.24 Billion USD	130.98%
2022 Q1	878 Million USD	400.68%
2021 Q4	-292 Million USD	82.56%
2021 FY	1.05 Billion USD	-79.54%
2021 Q1	1.89 Billion USD	27.44%
2021 Q2	1.12 Billion USD	-40.53%
2021 Q3	-1.67 Billion USD	-248.54%
2020 Q2	1.28 Billion USD	5.25%
2020 FY	5.16 Billion USD	76.54%
2020 Q1	1.22 Billion USD	111.44%
2020 Q3	1.17 Billion USD	-8.8%
2020 Q4	1.48 Billion USD	26.99%
2019 Q1	1.09 Billion USD	1.86%
2019 FY	2.92 Billion USD	-13.67%
2019 Q4	577 Million USD	-23.78%
2019 Q3	757 Million USD	53.55%
2019 Q2	493 Million USD	-55.06%
2018 FY	3.38 Billion USD	-7.89%
2018 Q1	696 Million USD	1.46%
2018 Q2	763 Million USD	9.63%
2018 Q3	851 Million USD	11.53%
2018 Q4	1.07 Billion USD	26.56%
2017 Q3	1.14 Billion USD	24.22%
2017 FY	3.67 Billion USD	-24.99%
2017 Q4	686 Million USD	-40.3%
2017 Q2	925 Million USD	0.87%
2017 Q1	917 Million USD	-63.8%
2016 Q4	2.53 Billion USD	146.4%
2016 FY	4.9 Billion USD	19.15%
2016 Q2	303 Million USD	-70.81%
2016 Q1	1.03 Billion USD	-4.6%
2016 Q3	1.02 Billion USD	239.27%
2015 Q3	1.17 Billion USD	26.76%
2015 Q2	923 Million USD	-1.07%
2015 FY	4.11 Billion USD	92.51%
2015 Q4	1.08 Billion USD	-7.01%
2015 Q1	933 Million USD	367.34%
2014 Q2	1.1 Billion USD	32.66%
2014 Q3	541 Million USD	-51.22%
2014 FY	2.13 Billion USD	-42.43%
2014 Q1	836 Million USD	241.46%
2014 Q4	-349 Million USD	-164.51%
2013 Q3	1.7 Billion USD	42.17%
2013 Q2	1.2 Billion USD	-14.1%
2013 FY	3.71 Billion USD	-54.44%
2013 Q1	1.39 Billion USD	-28.87%
2013 Q4	-591 Million USD	-134.64%
2012 Q4	1.96 Billion USD	-8.91%
2012 Q3	2.15 Billion USD	15.42%
2012 Q1	2.16 Billion USD	-0.32%
2012 FY	8.14 Billion USD	-36.32%
2012 Q2	1.86 Billion USD	-13.52%
2011 Q3	4.26 Billion USD	43.74%
2011 FY	12.79 Billion USD	11.32%
2011 Q4	2.16 Billion USD	-49.16%
2011 Q2	2.96 Billion USD	-12.82%
2011 Q1	3.4 Billion USD	41.06%
2010 Q4	2.41 Billion USD	0.21%
2010 FY	11.49 Billion USD	-0.42%
2010 Q1	3.64 Billion USD	56.69%
2010 Q3	2.4 Billion USD	-20.7%
2010 Q2	3.03 Billion USD	-16.72%
2009 FY	11.54 Billion USD	26.24%
2009 Q3	3.2 Billion USD	12.38%
2009 Q4	2.32 Billion USD	-27.43%
2009 Q1	3.16 Billion USD	67.18%
2009 Q2	2.85 Billion USD	-9.86%
2008 Q1	2.25 Billion USD	17.0%
2008 Q3	2.52 Billion USD	1.98%
2008 Q4	1.89 Billion USD	-24.98%
2008 Q2	2.47 Billion USD	9.57%
2008 FY	9.14 Billion USD	12.97%
2007 Q3	2.02 Billion USD	2.48%
2007 Q4	1.92 Billion USD	-4.6%
2007 Q2	1.97 Billion USD	-9.08%
2007 FY	8.09 Billion USD	-1.48%
2007 Q1	2.17 Billion USD	8.34%
2006 Q3	2.1 Billion USD	-1.17%
2006 Q2	2.13 Billion USD	7.84%
2006 Q1	1.97 Billion USD	20.78%
2006 FY	8.21 Billion USD	26.36%
2006 Q4	2 Billion USD	-4.89%
2005 Q2	1.71 Billion USD	18.24%
2005 Q4	1.63 Billion USD	-3.48%
2005 Q3	1.69 Billion USD	-1.34%
2005 Q1	1.45 Billion USD	149.07%
2005 FY	6.5 Billion USD	43.0%
2004 Q2	1.05 Billion USD	0.0%
2004 Q4	-2.96 Billion USD	-352.65%
2004 Q3	1.17 Billion USD	11.41%
2004 FY	4.54 Billion USD	10.61%
2004 Q1	1.05 Billion USD	23.91%
2003 Q1	1.27 Billion USD	74.24%
2003 FY	4.11 Billion USD	-5.67%
2003 Q4	849 Million USD	-22.46%
2003 Q3	1.09 Billion USD	22.63%
2003 Q2	892.92 Million USD	-29.92%
2002 FY	4.35 Billion USD	-22.94%
2002 Q4	731.21 Million USD	-18.78%
2002 Q2	1.06 Billion USD	-18.09%
2002 Q1	1.29 Billion USD	-52.06%
2002 Q3	900.32 Million USD	-15.38%
2001 Q2	940 Million USD	-8.44%
2001 Q4	2.7 Billion USD	166.96%
2001 Q3	1.01 Billion USD	7.98%
2001 FY	5.65 Billion USD	54.3%
2001 Q1	1.02 Billion USD	16.74%
2000 Q1	891.84 Million USD	453.47%
2000 Q3	918.65 Million USD	-5.82%
2000 Q4	879.41 Million USD	-4.27%
2000 FY	3.66 Billion USD	37.09%
2000 Q2	975.39 Million USD	9.37%
1999 Q1	4.52 Billion USD	185.53%
1999 FY	2.67 Billion USD	46.83%
1999 Q2	1 Billion USD	-77.68%
1999 Q3	908 Million USD	-10.01%
1999 Q4	-252.31 Million USD	-127.79%
1998 FY	1.82 Billion USD	1.71%
1998 Q3	2.33 Billion USD	365.11%
1998 Q1	2.41 Billion USD	153.89%
1998 Q4	-5.28 Billion USD	-326.88%
1998 Q2	501 Million USD	-79.28%
1997 Q4	-4.48 Billion USD	-313.7%
1997 Q1	2.28 Billion USD	182.79%
1997 Q3	2.09 Billion USD	-8.08%
1997 FY	1.79 Billion USD	0.23%
1997 Q2	2.28 Billion USD	0.0%
1996 FY	1.78 Billion USD	39.44%
1996 Q2	2.27 Billion USD	0.0%
1996 Q3	2.31 Billion USD	1.54%
1996 Q4	-2.75 Billion USD	-219.24%
1996 Q1	2.27 Billion USD	155.25%
1995 Q3	1.93 Billion USD	410.96%
1995 Q1	2.01 Billion USD	150.62%
1995 FY	1.28 Billion USD	24.33%
1995 Q4	-4.12 Billion USD	-313.11%
1995 Q2	378.7 Million USD	-81.23%
1994 Q1	1.83 Billion USD	145.75%
1994 Q2	1.83 Billion USD	0.0%
1994 Q4	-3.98 Billion USD	-327.32%
1994 FY	1.03 Billion USD	-1.06%
1994 Q3	1.75 Billion USD	-4.57%
1993 Q3	1.53 Billion USD	-12.1%
1993 Q4	-4.01 Billion USD	-361.21%
1993 Q1	1.74 Billion USD	0.0%
1993 Q2	1.74 Billion USD	0.0%
1993 FY	1.04 Billion USD	142.61%
1992 FY	429.22 Million USD	-66.37%
1991 FY	1.27 Billion USD	10.26%
1990 FY	1.15 Billion USD	0.0%

Peer Operating Income Comparison of AstraZeneca PLC

Name	Operating Income	Operating Income Difference
Amgen Inc.	7.89 Billion USD	-3.748%
Biogen Inc.	1.29 Billion USD	-531.786%
Gilead Sciences, Inc.	7.6 Billion USD	-7.732%
MIRA Pharmaceuticals, Inc.	-8.52 Million USD	96193.736%
Scilex Holding Company	-105.43 Million USD	7870.959%
Scilex Holding Company	-105.43 Million USD	7870.959%

Global Stocks Search

AstraZeneca PLC (AZN)

Operating Income Summary of AstraZeneca PLC

Annual Operating Income Chart of AstraZeneca PLC (2023 - 1990)

Historical Annual Operating Income of AstraZeneca PLC (2023 - 1990)

Peer Operating Income Comparison of AstraZeneca PLC